FDA Cleared

Transforming Lung Diagnostics with Precision AI

NEOPATHOLOGY, in partnership with V5Med, is delivering the state-of-the-art, FDA-Cleared Lung AI solution to US healthcare facilities. The Lung AI solution; increases radiologists diagnostic accuracy, reduces turnaround times, and empowers the diagnostic team.

Start Trial

The Diagnostic Bottleneck

Modern radiology faces growing challenges in lung nodule detection. As preventative screening increases, the volume of chest CT and X-ray scans is outpacing the growth of the radiologist workforce, leading to burnout and delayed diagnoses.1, 2 Beyond workforce shortages, several inherent diagnostic problems persist:

  • Tedious and Time-Consuming Analysis: The slide-by-slide and patient-by-patient reading process is labor-intensive, contributing significantly to reader fatigue.3
  • Variability in Interpretation: A lack of universal standard criteria for identifying vague but possible nodules leads to inconsistent diagnostic outcomes among radiologists.3
  • Difficulty with Small or Obscured Lesions: Small pulmonary lesions are easily missed, especially when situated close to or obscured by pulmonary blood vessels.4
  • High False-Positive Rates: Normal anatomical structures, such as vessel crossings, or benign findings like focal scarring and granulomas, are frequently misidentified as actionable nodules.4

The Lung AI solution bridges this critical gap by mitigating these detection and consequent diagnostic pitfalls, and reduces the cognitive load on radiologists.

US Scan Volume vs. Available Radiologists (Projected)

Illustrative data highlighting the widening resource gap.

References:

  1. Association of American Medical Colleges (AAMC). The Complexities of Physician Supply and Demand. A highlight of projected critical shortages in specialist physicians, including radiology, through the next decade.
  2. Chetlen AL, Chan TL et al. (2019) Addressing Burnout in Radiologists. Acad Radiol. 2019 Apr;26(4):526-533. doi: 10.1016/j.acra.2018.07.001. Epub 2018 Jul 31. PMID: 30711406.
  3. Chao et al. (2023) Artificial intelligence assisted computational tomographic detection of lung nodules for prognostic cancer examination: a large-scale clinical trial. Biomedicines 11(1), 147.
  4. Lo et al. (2018) Computer-Aided Detection of Lung Nodules on CT With a Computerized Pulmonary Vessel Suppressed Function. AJR Am J Roentgenol. 210(3):480-488.

Tailored Value for Every Stakeholder

The NEOPATHOLOGY-V5Med Lung AI solution delivers specific, measurable benefits across different segments of the healthcare ecosystem. Use the arrows to navigate through these value propositions and benefits.

🩺

Empowering Radiologists

Reduce fatigue and increase diagnostic confidence.

The NEOPATHOLOGY-V5Med Lung AI solution acts as a tireless concurrent reader, highlighting potential nodules and anomalies instantly. This reduces the mental load of searching for subtle lesions, allowing you to focus on complex characterization and diagnosis. Experience less screen fatigue and greater confidence in your reports.

13%
Reduction in interpretation
time, improving workflow efficiency
🏥

Optimizing Operations

Increase throughput without compromising quality.

For hospital administrators and imaging centers, The NEOPATHOLOGY-V5Med Lung AI solution means maximizing your existing resources. Clear patient backlogs faster, standardize reporting quality across your department, and improve overall departmental efficiency metrics with seamless PACS integration.

2.5x
Increase in departmental
throughput capacity
👥

Improving Patient Outcomes

Earlier detection when it matters most.

The ultimate goal is patient care. Lung AI identifies early-stage, subtle nodules that might otherwise be missed. Faster turnaround times mean patients spend less time waiting anxiously for results, enabling quicker pathways to treatment when intervention is most effective.

24%
Increased radiologists
detection sensitivity
FDA Cleared Technology

Proven Clinical Superiority

This visualization compares standard manual reading workflows against workflows augmented by our FDA-approved Lung AI solution. It demonstrates how integrating our solution elevates performance across all critical diagnostic dimensions without sacrificing accuracy for speed.

🎯

Unmatched Accuracy

Achieves >95% sensitivity in detecting small pulmonary nodules, acting as a reliable concurrent or second reader.

⚡

Rapid Turnaround

Processes standard chest scans in faster time, significantly reducing report turnaround time (RTAT).

🔄

Seamless Integration

Deployed and integrated directly into existing PACS/RIS with zero workflow disruption.

Ready to Modernize Your Radiology Workflow?

Partner with us. Get a personalized demonstration of our FDA-approved Lung AI and see how it works with your existing systems.

Live platform walkthrough
Seamless PACS/RIS integration analysis
Customized clinical ROI projection